Common Stock Warrants. As of September 19, 2008, the Company had the following outstanding warrants: Grant Date Expiration Date Warrants/ Options Granted Exercise Price Issued Class A Warrants: October, 2007 Convertible Notes Financing 10/23/2007 10/22/2012 2,818,181 0.50 January, 2008 Investment Banker Agreement 1/1/2008 12/31/2012 125,000 0.50 February, 2008 Convertible Notes Financing 2/15/2008 2/14/2013 1,515,151 0.50 April, 2008 Bridge Loans Financing 4/2-15/2008 4/1-13/2011 500,000 0.50 April, 2008 Finders Fees 4/14/2008 4/13/2013 62,500 0.50 May, 2008 Investment Banker Fees 5/19/2008 5/18/2013 37,500 0.50 May, 2008 Bridge Loan 5/19/2008 5/18/2011 100,000 0.50 June, 2008 Debt Extensions 6/23/2008 6/22/2011 150,000 0.50 June, 2008 Debt 6/26/2008 6/25/2013 303,030 0.50 July 2008 - Xxxxxx Stock 7/14/2008 7/14/2011 100,000 0.50 July 2008 - Xxxxx Xxxxxx 7/14/2008 7/14/2011 50,000 0.50 August 2008 - H. Xxxx Xxxxxxx 8/8/2008 8/7/2011 100,000 0.50 Total issued Class A Warrants 5,861,362 Other Issued Warrants: Supply Agreement 4/16/2008 4/15/2013 100,000 0.75 Warrants/ Options Granted Exercise Price Unissued Class B Warrants (i): October, 2007 Convertible Notes Financing 2,818,181 0.75 January, 2008 Investment Banker Financing 125,000 0.75 February, 2008 Convertible Notes Financing 1,515,151 0.75 April, 2008 Bridge Loans Financing 500,000 0.75 April, 2008 Finders Fees 62,500 0.75 May, 2008 Investment Banker Fees 37,500 0.75 May, 2008 Bridge Loan 100,000 0.75 June, 2008 Debt Extensions 150,000 0.75 June, 2008 Debt 303,030 0.75 July 2008 - Xxxxxx Stock 100,000 0.75 July 2008 - Xxxxx Xxxxxx 50,000 0.75 August 2008 - H. Xxxx Xxxxxxx 100,000 0.75 Total issued Class B Warrants 5,861,362
Common Stock Warrants. The Company shall have delivered to Investor Warrants attached as Exhibit E (the "Warrants") entitling Investor to purchase such number of shares of Common Stock (at the price at which the Company first sells any shares of its Common Stock to the public in a registered public offering, the "IPO Price") as equals $2,000,000 U.S. divided by such IPO Price. Such Warrants shall be exercisable only in connection with such initial public offering, shall expire upon completion of such offering, and shall be subject to compliance with applicable securities laws and regulations (including but not limited to the rules and policies of the National Association of Securities Dealers, Inc.). The Company shall use its best efforts to
Common Stock Warrants. Upon the making of each Advance under the --------------------- Notes, the Company shall issue to each Purchaser a Warrant representing the right to purchase 200 Warrant Shares for each $1,000 principal amount of such Advance, at an exercise price of $.70 per share. Each Warrant shall be exercisable for a period of three years from the date of issuance.
Common Stock Warrants. If we offer warrants for the purchase of common stock, a prospectus supplement relating to the warrants being offered will describe the terms of any common stock warrants, including the following: • the title of such warrants; • the offering price of such warrants, if any; • the aggregate number of such warrants; • the designation and terms of the common stock that is issued and purchasable upon exercise of such warrants; • if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; • if applicable, the date from and after which such warrants and any securities issued therewith will be separately transferable; • the number of shares of common stock that is issued and purchasable upon exercise of the warrants and the price which such shares may be purchased upon exercise; • the date on which the right to exercise such warrants shall commence and the date on which such right shall expire; • if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; • the currency, currencies or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, a discussion of certain United States federal income tax considerations; • the identity of the warrant agent for the warrants; • the anti-dilution provisions of the warrants, if any; • redemption or call provisions, if any, applicable to the warrants; and • any other terms of the warrants.
Common Stock Warrants. On December 27, 2013 and January 10, 2014, we issued common stock warrants to certain investors in a private placement of common stock and warrants (the “Common Stock Warrants”). The Common Stock Warrants have a five year term from each closing that occurred on December 27, 2013 and January 10, 2014, and are exercisable for an aggregate of up to 276,529 shares of our common stock at an initial per share exercise price of $9.00, subject to adjustments as set forth below. As of October 11, 2017 we have 193,197 shares of Common Stock Warrants outstanding. We may also call this warrant for redemption upon written notice to all warrant holders at any time the closing price of the common stock exceeds $15.00 (as may be adjusted pursuant to warrant agreement) for 20 consecutive trading days, as reported by Bloomberg, provided at such time there is an effective registration statement covering the resale of the shares underlying the warrants. In the 60 business days following the date the redemption notice is deemed given in accordance with the agreement, investors may choose to exercise this warrant or a portion of the warrant by paying the then applicable exercise price per share for every share exercised. Any shares not exercised on the last day of the exercise period will be redeemed by us at $0.001 per share. The exercise prices of the Common Stock Warrants are subject to adjustment upon certain events. If we at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination. Series B Warrants The Series B Warrants have a five year term from December 19, 2012 and are exercisable for an aggregate of up to 1,559,505 shares of our common stock at an initial per share exercise price of $2.48, subject to adjustment as set forth below. As of October 11, 2017, there were 1,317,195 warrants outstanding. These warrants have a cashless exercise provision. We also have a right of first refusal on the holder’s sale of the warrant shares. We may also call this warrant for redemption upon written notice to all warrant holders at ...
Common Stock Warrants. 16 11 Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . 158,113 170,701 Unrealized holding gains (losses) on available-for-sale securities, net of deferred taxes. . . . . . . . . . . . . . . . . . . (11) (11) Accumulated deficit. . . . . . . . . . . . . . . . . . . . . . . . . . . (115,729) (242,986) ------------------------- Total stockholders' equity . . . . . . . . . . . . . . . . . . . . . . . . 61,197 ( 52,868) ------------------------- Total liabilities and stockholders' equity . . . . . . . . . . . . . $1,141,380 $1,534,480 ------------------------- ------------------------- See accompanying Notes to Condensed Consolidated Financial Statements. ECHOSTAR COMMUNICATIONS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 1996 1997 1996 1997 REVENUE: DTH products and technical services . . . . . . . . . $ 60,458 $ 21,987 $ 97,199 $ 33,649 DISH Network promotions - subscription television services and products -- 43,943 -- 76,251 DISH Network subscription television services . . . . 5,582 32,189 6,046 57,588 C-band programming. . . . . . . . . . . . . . . . . . 3,194 1,916 6,643 4,079 Loan origination and participation income . . . . . . 4,290 787 5,103 1,278 Total revenue . . . . . . . . . . . . . . . . . . . . . 73,524 100,822 114,991 172,845 EXPENSES: DTH products and technical services . . . . . . . . . 57,528 18,231 90,278 27,718 DISH Network programming. . . . . . . . . . . . . . . 1,664 25,834 1,769 45,259 C-band programming. . . . . . . . . . . . . . . . . . 2,880 1,545 6,058 3,308 Selling, general and administrative . . . . . . . . . 19,083 34,362 29,816 66,389 Subscriber promotion subsidies. . . . . . . . . . . . -- 17,871 -- 31,013 Amortization of subscriber acquisition costs. . . . . 92 33,316 92 61,418 Depreciation and amortization . . . . . . . . . . . . 6,334 12,684 9,664 25,357 Total expenses. . . . . . . . . . . . . . . . . . . . . 87,581 143,843 137,677 260,462 Operating loss. . . . . . . . . . . . . . . . . . . . . (14,057) (43,021) (22,686) (87,617) Other Income (Expense): Interest income . . . . . . . . . . . . . . . . . . . 6,706 1,571 9,383 3,343 Interest expense, net of amounts capitalized. . . . . (27,141) (22,197) (33,184) (42,043) Other . . . . . . . . . . . . . . . . . . . . . . . . (117) (117) (134) (294) Total other income (expense). . . . . . . . . . . . . . (20,552) (20...
Common Stock Warrants. During 2006, the Company issued 4,200,000 warrants to an officer under his employment agreement. The Company recognized an expense of $126,435 for the period from inception to December 31, 2006. The Company recorded the fair value of the warrants based on the fair value of each warrant grant estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions used for grants in 2006, dividend yield of zero, expected volatility of 183%; risk-free interest rates of 4.98%, expected life of one year. The warrants vested immediately. The options expire between 5 and 9 years from the date of issuance and have an exercise price of between $.21 and $.40 per share. During November 2006, the Company and the officer entered into an amendment to the employment agreement whereby all the warrants were retired. XXXXX BIOCRAFT LABORATORIES, INC. (A DEVELOPMENT STAGE COMPANY) NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2007 and 2006 NOTE 4 COMMITMENTS AND CONTINGENCIES
Common Stock Warrants. In May 2001, we granted a corporation, which is a stockholder of RG America, a warrant to purchase 1,000,000 shares of our common stock at a price of $1.00 per share in exchange for $100,000 cash. The warrant exercise period was to commence upon the granting of free trading shares in an Arkansas corporation, which had filed for federal bankruptcy protection under Chapter 11 of the federal bankruptcy laws. We were under contract to purchase this corporation from the federal bankruptcy trustee at the time the warrant was issued. The contract to purchase this corporation was subsequently terminated. As a result, in February 2002, we amended the warrant agreement to grant an option to purchase 2,000,000 shares of RG's $.001 par value common stock at a price of $.50 per share. The warrants expire February 28, 2005. In May 2004, we granted a corporation, which is a stockholder of RG America, a warrant to purchase 1,000,000 shares of our common stock at a price of $0.10 per share in exchange for previous and ongoing financial advisory services to assist the Company. We determined that the fair market value of the services provided was $30,000 based upon comparable services in the marketplace and the entire $30,000 has been recorded against additional paid-in-capital. In June 2004, we granted a corporation, which is a strategic partner of RG America, a warrant to purchase 2,000,000 shares of our common stock through June 2009 at a price of $1.00 per share in exchange current and ongoing strategic financial services. You should read the following selected financial data together with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the financial statements and the notes thereto included elsewhere in this Memorandum.
Common Stock Warrants. The Company will take all necessary and appropriate action so that each Common Stock Warrant outstanding immediately prior to the Effective Time will, effective as of the Effective Time, be terminated and converted into the right to receive, without interest, for each share of Voting Common Stock subject thereto, (A) the Per Share Rights Amount, (B) an amount equal to the excess, if any, of the Per Common Share Closing Consideration over the exercise price per share of such Common Stock Warrant immediately prior to the Effective Time and (C) any Per Common Share Contingent Consideration payable from time to time pursuant to Section 3.4, in each case payable in cash to the holder thereof, subject to applicable Tax withholding. From and after the Effective Time, all Common Stock Warrants will no longer be outstanding and will be automatically cancelled and will cease to exist, and each such warrant will cease to have any rights with respect thereto, except the right to receive (subject to the terms of this Agreement) the consideration with respect to such warrant set forth in this Section 3.1(e)(iii). Within two (2) business days after the execution and delivery of this Agreement, the Company will deliver to each holder of a Common Stock Warrant any notice contemplated by the Common Stock Warrants regarding the Merger and the other transactions contemplated hereby.
Common Stock Warrants. 3 Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
